A multicenter proton magnetic resonance spectroscopy study of neurological complications of AIDS

AIDS Research and Human Retroviruses

Volumn 12, Issue 3, 1996, Pages 213-222

  Paley, M ^a,g   Cozzone, P J ^b   Alonso, J ^c   Vion Dury, J ^b   Confort Gouny, S ^b   Wilkinson, I D ^a   Chong, W K ^a   Hall Craggs, M A ^a   Harrison, M J G ^a   Gili, J ^c   Rovira, A ^c   Capellades, J ^c   Rio, J ^d   Ocana, I ^d   Nicoli, F ^b,e   Dhiver, C ^e   Gastaut, J L ^e   Gastaut, J A ^e   Wicklow, K ^f   Sauter, R ^f  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b University of Aix Marseille   (France)

^c Institut de Diagnostic per la Imatge   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e HÔPITAL SAINTE MARGUERITE   (France)

^f SIEMENS AG   (Germany)

^g MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAIN ATROPHY; BRAIN METABOLISM; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REPRODUCIBILITY; VIRUS TRANSMISSION; WHITE MATTER;

EID: 0030040837     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.213     Document Type: Article

References (30)

1. Sauter R: Cerebral Single Volume Proton Spectroscopy on Healthy Volunteers: A Multicenter Pilot Study. Society of Magnetic Resonance in Medicine, 12th Annual Meeting, 1993, New York, Abstract 1531.
2. Council of State and Territorial Epidemiologists: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. AIDS Program, Center for Infectious Diseases. MMWR 1987;36(Suppl. 1):1S-15S.
3. Menon DK, Baudouin CJ, Tomlinson D, and Hoyle C: Proton MR spectroscopy and imaging of the brain in AIDS: Evidence of neuronal loss in regions that appear normal with imaging. J Comput Assist Tomogr 1990;14(6):882-885.
4. Menon DK, Ainsworth JG, Cox IJ, Coker RC, Sargentoni J, Coutts GA, Baudouin CJ, Kocsis AE, and Harris JRW: Proton MR spectroscopy of the brain in AIDS dementia complex. J Comput Assist Tomogr 1992;16(4):538-542.
5. Jarvick JG, Lenkinski RE, Grossman RI, Gomori JM, Scnall MD, and Frank I: Proton MR spectroscopy in HIV-infected patients: Characterization of abnormalities with imaging and clinical correlation. Radiology 1993;186:739-744.
6. Meyerhoff DJ, MacKay S, Bachman L, Poole N, Dillon WP, Weiner MW, and Fein G: Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus seropositive individuals: In-vivo magnetic resonance spectroscopic imaging. Neurology 1993;43:509-515.
7. 1H-MRS in HIV Infection and AIDS. Society of Magnetic Resonance in Medicine, 11th Annual Meeting, 1992, Berlin, Abstract 1942.
8. 1H-MRS in HIV infection: Clinical, immunological and neurological correlations. Radiology 1993;188:119-124.
9. McConnell JR, Swindells S, Ong CH, Gmeiner WH, Chu WK, Brown DK, and Gendelman HE: Prospective utility of cerebral magnetic resonance spectroscopy in monitoring HIV infection and its associated neurological impairment. AIDS Res Hum Retroviruses 1994;10(8):977-982.
10. Confort-Gouny S, Vion-Dury J, Nicoli F, Dano P, Donnet A, Grazziani N, Gastaut JL, Grisoli F, and Cozzone PJ: A multiparametric analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological diseases. Neurol Sci 1993;118:123-133.
11. Laubenberger J, Hennig J, Haussinger D, Naumann R, Gaida E, Hass G, and Wakhloo K: Proton Spectroscopy of the Brain in HIV-Infected Patients. Society of Magnetic Resonance in Medicine, 11th Annual Meeting, 1992, Berlin, Abstract 758.
12. Vion-Dury J, Confort-Gouny S, Nicoli F, Dhiver C, Gastaut JL, Gastaut JA, and Cozzone PJ: Localized brain proton MRS metabolic patterns in HIV-related encephalopalhies. CR Acad Sci (Paris) 1994;317:833-840.
13. Vion-Dury J, Meyerhoff DJ, Cozzone PJ, and Weiner MW: What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? J Neurol 1994;241:354-371.
14. Michaelis T, Merboldt KD, Bruhn H, Hänicke W, Math D, and Frahm J: Absolute concentrations of metabolites in the adult human brain in vivo: Quantification of localized proton MR spectra. Radiology 1993;187:219-227.
15. Nadler JV and Cooper JR: N-Acetyl-L-aspartic acid content of human neural tumours and bovine peripheral nervous tissues. J Neurochem 1972;19:313-319.
16. 1H-NMR spectroscopic studies of the brain. Neurosci Biobehav Rev 1989;13:23-31.
17. Koller KJ, Zaczek R, and Coyle R: N-Acetyl-aspartyl glutamate regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J Neurochem 1984;43:1136-1142.
18. 1H NMR spectroscopy: N-Acetyl-L-aspartate, creatine and choline. NMR Biomed 1991;4:47-52.
19. Working Group of the American Academy of Neurology AIDS Task Force: Nomenclature and research case definition for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 1991;41:778-785.
20. Paley M, Chong WK, Wilkinson ID, Shepherd JK, Clews AM, Sweeney BJ, Hall-Craggs MA, Kendall BE, Newman SP, and Harrison JG: CSF to intracranial volume ratio measurements in HIV infection using the CLASS image analysis technique. Radiology 1994;190:879-886.
21. o field shifts following the application of pulsed gradients by phase correction in the time domain. J Magn Res, 1986;69:151-155.
22. LeClerc JHJ: The pseudo-Wigner distribution of double and triple resonances. J Magn Res 1992;100:171-182.
23. Paley M, Wilkinson ID, Chong WK, Shepherd JK, Clews A, Hall-Craggs MA, and Harrison MJG: Short Echo Time Spectroscopy in AIDS. Society of Magnetic Resonance in Medicine, 12th Annual Meeting, 1993, New York, Abstract 1561.
24. Everall IP, Luthbert PJ, and Lantos PL: Neuronal loss in the frontal cortex in HIV infection. Lancet 1991;337:1119-1121.
25. Everall IP, Luthbert PJ, and Lantos PL: Neuronal Number and Volume Alterations in the Neocortex of HIV Infected Individuals. IVth International Conference: The Neuroscience of HIV Infection: Basic and Clinical Frontiers, Amsterdam, 1992, Abstract 71.
26. Manji H, Connolly S, McAllister R, Valentine AR, Kendall BE, Fell M, Durance P, Thompson AJ, Newman S, Weller IVD, and Harrison MJG: Serial MRI of the brain in asymptomatic patients infected with HIV: Results from the UCMSM/Medical Research Council neurology cohort. J Neurol Neurosurg Psychiatr 1994;57:144-149.
27. Selnes OA, McArthur JC, Royal W III, Updike ML, Nance-Spronson T, Concha M, Gordon B, Solomon L, and Vlahov D: HIV-1 infection and intravenous drug use: Longitudinal neuropsychological evaluation of asymptomatic subjects. Neurology 1992;42:1924-1930.
28. Kaslow RA, Blackwelder WC, Ostrow DG, Yerg D, Palenicek J, Coulson AH, and Valsieserri RO: No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1 positive individuals. JAMA 1989;261:3424-3429.
29. Wilkinson ID, Hall-Craggs MA, Chong WK, Paley M, Shepherd JK, Noble P, Harrison MJG, and Weller IVD: Increase in NA/Cr metabolite ratio following antiretroviral treatment: A case study. Society of Magnetic Resonance in Medicine, 12th Annual Meeting, 1993, New York, Abstract 1560.
30. Vion Dury J, Nicoli F, Salvan AM, Confort-Gouny S, Dhiver C, and Cozzone PJ: Reversal of brain metabolic alterations with zidovudine detected by proton localized magnetic resonance spectroscopy. Lancet 1995;345:60-61.